These results suggest that PAI‐1 could potentially serve as a targeted regulatory factor for tumor‐initiating cells in HNC, thus highlighting the therapeutic potential of inhibiting PAI‐1 as a strategy to target these cells. This evidence concerns the gene SERPINE1 and neoplasm.